Carregant...
SETD2: a complex role in blood malignancy
In this issue of Blood, Mar et al describe the effect of inactivating mutations of the histone methyltransferase (HMT) SETD2 in accelerating leukemia pathogenesis and conferring therapy resistance.(1) Mutations of epigenetic regulators are among the commonest lesions in malignancy. These include mut...
Guardat en:
| Publicat a: | Blood |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731090/ https://ncbi.nlm.nih.gov/pubmed/29242204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-10-811927 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|